Beta-glucans is a Potential Inhibitor of Ovarian Cancer: Based on Molecular and Biological Aspects.

Sadoughi, Fatemeh; Asemi, Zatollah; Hallajzadeh, Jamal; Mansournia, Mohammad Ali; Yousefi, Bahman

Sadoughi, Fatemeh; Asemi, Zatollah; Hallajzadeh, Jamal; Mansournia, Mohammad Ali; Yousefi, Bahman.

Afiliação

Sadoughi F; Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, I.R. Iran.
Asemi Z; Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences, Kashan University of Medical Sciences, Kashan, I.R. Iran.
Hallajzadeh J; Department of Biochemistry and Nutrition, Research Center for Evidence-Based Health Management, Maragheh University of Medical Sciences, Maragheh, Iran.
Mansournia MA; Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Yousefi B; Molecular Medicine Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Curr Pharm Biotechnol ; 23(9): 1142-1152, 2022.

Article em En | MEDLINE | ID: mdl-34375183

Assuntos

Antineoplásicos; Neoplasias Ovarianas; beta-Glucanas; Antineoplásicos/farmacologia; Antineoplásicos/uso terapêutico; Apoptose; Carcinoma Epitelial do Ovário; Feminino; Humanos; Neoplasias Ovarianas/tratamento farmacológico; beta-Glucanas/uso terapêutico

Palavras-chave

Beta-glucans; anti-cancer; apoptosis; ovarian cancer; ovaries; signaling

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Beta-Glucanas / Antineoplásicos Limite: Female / Humans Idioma: En Revista: Curr Pharm Biotechnol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google